Home Cart Sign in  
Chemical Structure| 83-48-7 Chemical Structure| 83-48-7

Structure of Stigmasterol
CAS No.: 83-48-7

Chemical Structure| 83-48-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Stigmasterol is among the most abundant of plant sterols used as a food additive, with potential effect on lowering the levels of LDL cholesterol.

Synonyms: Stigmasterin; 5,22-Cholestadien-24-beta-ethyl-3-beta-ol

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Stigmasterol

CAS No. :83-48-7
Formula : C29H48O
M.W : 412.69
SMILES Code : CC[C@](C(C)C)([H])/C([H])=C([H])/[C@@]([C@@]1([H])CC[C@@]2([H])[C@]([C@]3([H])CC[C@]12C)([H])CC=C4C[C@](O)([H])CC[C@@]43C)([H])C
Synonyms :
Stigmasterin; 5,22-Cholestadien-24-beta-ethyl-3-beta-ol
MDL No. :MFCD00003630
InChI Key :HCXVJBMSMIARIN-PHZDYDNGSA-N
Pubchem ID :5280794

Safety of Stigmasterol

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00698256 Hypercholesterolemia Not Applicable Completed - Finland ... More >> University of kuopio Kuopio, Finland, 70211 Less <<
NCT02702947 BPH Phase 4 Completed - India ... More >> Department of Urology, King George's Medical University, Lucknow, UP, India Lucknow, Uttar Pradesh, India, 226003 Less <<
NCT00718796 Cardiovascular Disease Phase 3 Completed - Canada, Ontario ... More >> Canadian College of Naturopathic Medicine Toronto, Ontario, Canada, M2K 1E2 Less <<
NCT01010841 Metabolic Syndrome ... More >> Overweight Obesity Hypercholesterolemia Less << Not Applicable Completed - United States, Florida ... More >> Mark McIntosh MD Jacksonville, Florida, United States, 32209 Less <<
NCT03739242 Hypercholesterolemia Not Applicable Completed - Italy ... More >> Policlinico S.Orsola - Malpighi Medicina Interna Borghi Bologna, Italy, 40138 Less <<
NCT02221973 Primary Dyslipidemia Not Applicable Completed - China ... More >> Anzhen Hospital, Capital University of Medical Sciences Beijing, China Chao Yang 2nd Hospital Beijing, China Chui Yang Liu Hospital Beijing, China Less <<
NCT01954472 Cardiovascular Diseases ... More >> Type 2 Diabetes Hypercholesterolemia Less << Not Applicable Withdrawn(This study was combi... More >>ned with another CIHR funded study (NCT02078635). Both studies involve the same dietary portfolio and the same study population.) Less << - Canada, British Columbia ... More >> Healthy Heart Lipid Clinic, St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Manitoba Richardson Center for Functional Foods and Nutraceuticals and the St. Boniface Hospital Cardiovascular Center, University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 Canada, Ontario Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Canada, Quebec Institute of Nutraceuticals and Functional Foods and the Quebec Heart and Lung Institute, Laval University Quebec City, Quebec, Canada, G1V 4G2 Less <<
NCT02481466 Cardiovascular Diseases ... More >> Hypercholesterolemia Type 2 Diabetes Metabolic Syndrome Less << Not Applicable Recruiting December 2022 Canada, British Columbia ... More >> Healthy Heart Lipid Clinic, St. Paul's Hospital Recruiting Vancouver, British Columbia, Canada, V6Z 1Y6 Principal Investigator: Jiri Frohlich, MD          Canada, Manitoba Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Not yet recruiting Winnipeg, Manitoba, Canada, R3T 6C5 Contact: Peter Jones, PhD          Principal Investigator: Peter Jones, PhD          Canada, Ontario Risk Factor Modification Centre, St. Michael's Hospital Recruiting Toronto, Ontario, Canada, M5C 2T2 Contact: David J Jenkins, MD PhD    416-867-7475    David.jenkins@utoronto.ca    Contact: Dorothea A Faulkner, PhD    416-360-4000 ext 48175    FaulknerD@smh.ca    Principal Investigator: David J Jenkins, MD PhD          Sub-Investigator: Cyril Kendall, PhD          Sub-Investigator: Robert Josse, MD          Sub-Investigator: Lawrence Leiter, MD          Sub-Investigator: John Sievenpiper, MD PhD          Sub-Investigator: Anish Kirpalani, MD          Canada, Quebec Institute of Nutraceuticals and Functional Foods, Laval University Recruiting Quebec City, Quebec, Canada, G1V 4G2 Contact: Benoit Lamarche, PhD          Principal Investigator: Benoit Lamarche, PhD Less <<
NCT00345722 Hyperlipidemia ... More >> Cardiovascular Diseases Hypercholesterolemia Less << Phase 2 Completed - Canada, Ontario ... More >> Clinical Nutrition & Risk Factor Modification Centre, St. Michael's Hospital Health Centre Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT03681392 Prostatism Er... More >>ectile Dysfunction Less << Not Applicable Not yet recruiting March 2020 -
NCT01031485 Stage 1 Hypertension Phase 3 Completed - Finland ... More >> Valio Ltd Helsinki, Uusimaa, Finland, 00370 Less <<
NCT03728244 Graft Pain Gi... More >>ngival Recession Less << Phase 1 Phase 2 Not yet recruiting August 2020 -
NCT00249938 Hyperlipidemia ... More >> Dyslipidemia Less << Phase 4 Completed - United States, Colorado ... More >> University of Colorado at Denver and Health Sciences Center Denver, Colorado, United States, 80262 Less <<
NCT03534414 - Active, not recruiting October 1, 2018 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Micheal's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT01584206 Sitosterolemia Not Applicable Unknown December 2016 Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 2N2 Less <<
NCT00438425 Hyperlipidemia ... More >> Cardiovascular Disease Less << Not Applicable Completed - Canada, British Columbia ... More >> Healthy Heart Program, St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Manitoba Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 Canada, Ontario Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Canada, Quebec Institute on Nutraceuticals and Functional Foods and the Lipid Research Center, Laval University Hospital Research Center Quebec City, Quebec, Canada, G1V 4G2 Less <<
NCT00793364 Hypercholesterolemia Phase 4 Completed - Greece ... More >> Aristotelian University, Hippocration Hospital Thessaloniki, Greece, 55132 Less <<
NCT01948648 Sitosterolemia Not Applicable Recruiting December 31, 2019 Canada, Manitoba ... More >> Richardson Center for Functional Foods and Nutraceuticals Recruiting Winnipeg, Manitoba, Canada Contact: Semone B Myrie, PhD    204-272-1555    myrie@cc.umanitoba.ca    Contact: Peter J Jones, PhD    204-474-8883    Peter.Jones@umanitoba.ca    Sub-Investigator: Semone B Myrie, PhD          Principal Investigator: Peter J Jones, PhD          Sub-Investigator: David Mymim, PhD          Sub-Investigator: Taback Shayne, PHD Less <<
NCT01084226 Hypercholesterol Phase 2 Completed - Finland ... More >> Folkhälsan Research Center Helsinki, Finland, 00290 Less <<
NCT02078635 Cardiovascular Diseases ... More >> Hypercholesterolemia Diabetes Metabolic Syndrome Obesity Less << Not Applicable Withdrawn(Study was amalgamate... More >>d with another study to include exercise as another intervention.) Less << - Canada, British Columbia ... More >> Healthy Heart Lipid Clinic, St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Manitoba Richardson Center for Functional Foods and Nutraceuticals and the St. Boniface Hospital Cardiovascular Center, University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 Canada, Ontario Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Canada, Quebec Institute of Nutraceuticals and Functional Foods and the Quebec Heart and Lung Institute, Laval University Quebec City, Quebec, Canada, G1V 4G2 Less <<
NCT01629238 - Completed - France ... More >> BKL Consultant Boulogne-Billancourt, France, 92100 Less <<
NCT00924391 Coronary Heart Disease Phase 2 Completed - Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 2N2 Less <<
NCT00923403 Hypercholesterolemia Phase 1 Phase 2 Completed - Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 6C5 Less <<
NCT00438893 Hyperlipidemia ... More >> Cardiovascular Diseases Hypercholesterolemia Less << Not Applicable Completed - Canada, Ontario ... More >> Clinical Nutrition & Risk Factor Modification Centre, St. Michael's Hospital Health Centre Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT00846937 Ileostoma Not Applicable Completed - Finland ... More >> University of Helsinki, Department of Medicine Helsinki, Finland, 00029 Less <<
NCT00940849 Gastric Emptying Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Limburg, Netherlands, 6200 Less <<
NCT00802516 Hypercholesterolemia Not Applicable Completed - Netherlands ... More >> Maastricht University Maastricht, Netherlands, 6229ER Less <<
NCT03469518 Hypercholesterolemia ... More >> Osteoporosis Postmenopausal Disorder Less << Not Applicable Active, not recruiting December 2018 -
NCT03065491 Hypercholesterolemia Not Applicable Completed - Italy ... More >> S. Orsola-Malpighi University Hospital Bologna, BO, Italy, 40138 Less <<
NCT00441857 Hypercholesterolemia Phase 4 Completed - Finland ... More >> Oy Foodfiles Ltd Kuopio, Finland, 70210 Less <<
NCT01521169 Normal and Mild Hypercholester... More >>olemic Subjects Less << Not Applicable Completed - Japan ... More >> Senrichuo Ekimae Clinic - Senri Life Science Center 13F Osaka, Japan, 560-0082 Less <<
NCT03312816 Healthy Not Applicable Completed - Germany ... More >> Charité Research Organisation GmbH Berlin, Germany, 10117 Less <<
NCT02732223 Cardiovascular Diseases Not Applicable Completed - -
NCT01932840 - Completed - Canada, Ontario ... More >> University of Guelph Guelph, Ontario, Canada Less <<
NCT01600820 Hypercholesterolemia Not Applicable Completed - Spain ... More >> Hospital de Sant Joan Reus, Spain, 43201 Less <<
NCT00422266 Dyslipidemia Phase 3 Completed - India ... More >> National Thermal Power Corporation Delhi, Badarpur, India Less <<
NCT00485095 High Blood Cholesterol Level Phase 4 Completed - Norway ... More >> Lipidklinikken, Rikshospitalet Radiumhospitalet HF Oslo, Norway Rikshospitalet Radiumhospitalet HF, Oslo, Norway Oslo, Norway Less <<
NCT01882517 Hypercholesterolemia ... More >> Hyperlipidemias Dyslipidemias Less << Not Applicable Completed - Turkey ... More >> Hacettepe University Ankara, Turkey Less <<
NCT01716390 Hypercholesterolemia Not Applicable Completed - Sweden ... More >> Good Food Practice Uppsala, Sweden Less <<
NCT00222950 - Unknown - Germany ... More >> University of the Saarland Recruiting Homburg, Saarland, Germany, 66421 Contact: Oliver Weingartner, M.D.    0049-(0)68411623372    oweingartner@aol.com    Contact: Ulrich Laufs, M.D.    0049-(0)68411623372    ulrich@laufs.com    Sub-Investigator: Oliver Weingartner, M.D. Less <<
NCT01825668 Hypercholesterolemia ... More >> CVD Less << Not Applicable Unknown June 2016 Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 2N2 Less <<
NCT01340287 Hypercholesterolemia Not Applicable Completed - United States, Florida ... More >> Renstar Medical Research Ocala, Florida, United States Less <<
NCT01478789 Hypercholesterolemia Not Applicable Completed - Canada, Manitoba ... More >> Richarson Centre for Funtional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 2N2 Less <<
NCT01461798 Risk Reduction Behavior Not Applicable Unknown March 2012 -
NCT00897975 Hyperlipidemia Phase 2 Phase 3 Completed - United States, Pennsylvania ... More >> Abington Memorial Hospital Abington, Pennsylvania, United States Chestnut Hill Hospital Philadelphia, Pennsylvania, United States, 19118 Less <<
NCT02628990 Hypercholesterolemia ... More >> Hyperlipidemias Dyslipidemias Less << Not Applicable Completed - -
NCT01629888 Healthy Mild ... More >>Hypercholesterolemia Less << Not Applicable Completed - Japan ... More >> Senri Chuo Ekimae Clinic Osaka, Japan, 560-0082 Less <<
NCT00145717 Hypercholesterolemia ... More >> Cardiovascular Diseases Less << Phase 3 Completed - China ... More >> Peking University Health Science Centre Beijing, China, 100083 Less <<
NCT02947594 - Completed - -
NCT01574469 Mildly Hypercholesterolemic Su... More >>bjects Less << Not Applicable Completed - France ... More >> Hôpital Pitié-Salpêtrière Paris, France, 75013 Less <<
NCT02475018 Hypercholesterolemia Not Applicable Completed - China, Beijing ... More >> BaiZhiFang Community Health Service Centre Beijing, Beijing, China, 100053 Less <<
NCT01313988 Healthy Mildl... More >>y Elevated Cholesterol Levels Less << Not Applicable Completed - Sweden ... More >> KPL Good Food Practice AB Uppsala, Sweden, S-751 83 Less <<
NCT00863265 Hypercholesterolemia ... More >> Coronary Heart Disease Less << Early Phase 1 Completed - United States, Utah ... More >> Center for Advance Nutrition at Utah State University Logan, Utah, United States, 84322-4715 Less <<
NCT02779673 LDL-cholesterol Level 130-159m... More >>g/dL Less << Not Applicable Completed - -
NCT02221297 Hypercholesterolemia ... More >> Hyperlipidemias Dyslipidemias Less << Not Applicable Completed - -
NCT01574482 Mildly Hypercholesterolemic Su... More >>bjects Less << Not Applicable Completed - Italy ... More >> Ospedale Silvestrini Perugia, Italy, 06129 Less <<
NCT00863265 - Completed - -
NCT01571869 Mildly Hypercholesterolemic Su... More >>bjects Less << Not Applicable Completed - Canada, Quebec ... More >> McGill University Ste-anne-de-bellevue, Quebec, Canada, H9X 3V9 Less <<
NCT02316808 Dyslipidemias ... More >> Hypercholesterolemia Hyperlipidemias Less << Not Applicable Completed - -
NCT00153738 Hypercholesteremia Not Applicable Completed - United States, Texas ... More >> The Cooper Institute Dallas, Texas, United States, 75230 Less <<
NCT01521156 Mild Hypercholesterolemic Subj... More >>ects Less << Not Applicable Completed - Germany ... More >> Harrison Clinical Research Clinical Unit Munich, Germany, 80636 Less <<
NCT03705767 - Completed - -
NCT01571882 Mildly Hypercholesterolemic Su... More >>bjects Less << Not Applicable Completed - United Kingdom ... More >> Guildford Clinical Pharmacology Unit Ltd. (Gcpl) Guildford, Surrey, United Kingdom, GU2 7YG Less <<
NCT02459314 Hypercholesterolemia Not Applicable Completed - Thailand ... More >> Clinical trial Unit, Faculty of Medicine, Chiang Mai University Muang, ChiangMai, Thailand, 50200 Less <<
NCT02644109 Dyslipidemias ... More >> Hypercholesterolemia Less << Phase 4 Completed - Chile ... More >> Instituto de Nutricion y Tecnologia de los Alimentos, Universidad de Chile Santiago, Región Metropolitana de Santiago, Chile Department of Nutrition, Diabetes and Metabolism. Pontificia Universidad Catolica de Chile Santiago, Chile Less <<
NCT01205308 Type 1 Diabetes Not Applicable Completed - Finland ... More >> University of Eastern Finland Kuopio, Finland, FIN-70211 Less <<
NCT02765516 Hypercholesterolemia ... More >> Cardiovascular Disease Less << Not Applicable Recruiting December 2019 Canada, Manitoba ... More >> Department of Human Nutritional sciences, University of Manitoba Recruiting Winnipeg, Manitoba, Canada, R3T2N2 Contact: James House, PhD    204-474-6837    james.house@umanitoba.ca    Principal Investigator: James House, PhD Less <<
NCT03284918 Hypercholesterolemia ... More >> Hyperlipidemias Dyslipidemias Less << Not Applicable Completed - -
NCT00738933 Hypercholesterolemia ... More >> Atherosclerosis Less << Not Applicable Unknown December 2011 Finland ... More >> Department of Medicine, Div. of Internal Medicine, Helsinki Univ. Central Hospital (HUCH) Recruiting Helsinki, Finland, 00029HUS Contact: Markku Nissinen, MD, PhD    +358 9 4711    markku.nissinen@hus.fi    Principal Investigator: Tatu A Miettinen, Professor          Sub-Investigator: Markku J Nissinen, MD, PhD Less <<
NCT02644109 - Completed - -
NCT01715675 Asthma Allerg... More >>y Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Centre Maastricht, Limburg, Netherlands, 6229ER Less <<
NCT00720720 Hypercholesterolemia Not Applicable Terminated(Recruitment and org... More >>anizational difficulties) Less << - France ... More >> Hôpital cardio-vasculaire et pneumologique Louis Pradel Bron, France, 69677 Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition Nantes, France, 44093 Groupe Hospitalier Pitié-Salpêtrière, Endocrinology and Metabolism Department Paris, France, 75013 Less <<
NCT00920894 Elevated Blood Lipids Not Applicable Completed - Finland ... More >> Clinical Life Sciences Ltd Vuokatti, Finland, 88610 Less <<
NCT00441480 - Completed - -
NCT03723330 Cardiovascular Diseases ... More >> Endothelial Dysfunction Metabolic Syndrome Diet Modification Less << Not Applicable Not yet recruiting May 2020 -
NCT00441480 Dyslipidemia Phase 4 Completed - Israel ... More >> Sheba medical center Tel-HaShomer, Israel, 52621 Less <<
NCT02603276 Hypercholesterolemia Not Applicable Completed - Italy ... More >> S. Orsola-Malpighi University Hospital Bologna, Italy, 40038 Less <<
NCT00737919 Atherosclerosis Not Applicable Completed - Finland ... More >> Department of Surgery, Div. of Vascular Surgery, Helsinki University Central Hospital Helsinki, Finland, 00029 Less <<
NCT02969720 Metabolic Syndrome x Phase 3 Unknown December 2017 -
NCT00860054 Hypercholesterolemia ... More >> Coronary Heart Disease Less << Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT02728583 Vascular Diseases ... More >> Hypercholesterolemia Less << Not Applicable Completed - Germany ... More >> Charite Research Organisation Berlin, Germany Less <<
NCT02278393 Healthy Volunteers Not Applicable Completed - Japan ... More >> Yaesu Sakura-dori Clinic Tokyo, Japan, 103-0028 Less <<
NCT01712867 Patients With Hypertriglycerid... More >>emia Less << Not Applicable Completed - Israel ... More >> Maccabi Healthcare Services Tel-Aviv, Israel Less <<
NCT01803178 Vascular Diseases ... More >> Hypercholesterolemia Less << Not Applicable Completed - Germany ... More >> Charité Research Organisation Berlin, Germany Less <<
NCT00860509 Hypercholesterolemia ... More >> Coronary Heart Disease Less << Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center-Louisana State University System Baton Rouge, Louisiana, United States, 70808 Less <<
NCT02065024 Hypercholesterolemia ... More >> Osteoporosis Less << Phase 1 Completed - Spain ... More >> Hospital Universitario Puerta de Hierro-Majadahonda Majadahonda (Madrid), Madrid, Spain, 28222 Less <<
NCT02268318 Subjects With High LDL-Cholest... More >>erol Less << Not Applicable Completed - Japan ... More >> Yaesu Sakura-dori Clinic Tokyo, Japan, 103-0028 Less <<
NCT02758834 - Completed - -
NCT02881658 Dyslipidemia Not Applicable Completed - Hong Kong ... More >> Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam Hong Kong, Hong Kong Less <<
NCT02881658 - Completed - -
NCT01574417 Hypercholesterolemia Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Centre Maastricht, Limburg, Netherlands Less <<
NCT01559428 Normocholesterolemic Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Centre Maastricht, Limburg, Netherlands, 6229 ER Less <<
NCT01406106 Hypercholesterolemia Not Applicable Unknown December 2012 -
NCT01315964 Atherosclerosis Not Applicable Completed - Finland ... More >> Biomedicum Helsinki Helsinki, Finland, 00029 Less <<
NCT01102647 Cardiovascular Disease Phase 1 Completed - Canada, Manitoba ... More >> University of Manitoba Winnipeg, Manitoba, Canada, R3T 2N2 Less <<
NCT02288585 Vascular Diseases ... More >> Hypercholesterolemia Diabetes Mellitus Less << Not Applicable Completed - Australia ... More >> CSIRO Adelaide, Australia CSIRO, North Ryde Sydney, Australia Less <<
NCT01074723 Postmenopausal Disorder Phase 1 Completed - Spain ... More >> Puerta de Hierro University Hospital Madrid, Spain, 28222 Less <<
NCT03627819 Non-Alcoholic Fatty Liver Dise... More >>ase Less << Not Applicable Recruiting December 2019 Netherlands ... More >> Maastricht University Medical Centre Recruiting Maastricht, Limburg, Netherlands, 6229 ER Contact: Sabine Baumgartner, Dr.    +31 (0)43 3881305    sabine.baumgartner@maastrichtuniversity.nl Less <<
NCT02089867 Coronary Artery Disease Phase 2 Phase 3 Completed - Brazil ... More >> Jose Rocha Faria Neto Curitiba, Paraná, Brazil, 80215-901 Less <<
NCT02331043 Dyslipidemias ... More >> Hypercholesterolemia Hyperlipidemias Less << Not Applicable Completed - Thailand ... More >> Mahidon University, Nutrition Institute, Center of Innovation and Reference on Food for Nutrition (CIRFON) Phutthamonthon, Nakhon Pathom, Thailand, 73170 Less <<
NCT01131832 Hyperlipidemia Phase 4 Completed - United States, Maryland ... More >> USDA-ARS, Beltsville Human Nutrition Research Center Beltsville, Maryland, United States, 20705 Canada, Manitoba Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 Less <<
NCT01875978 Non-alcoholic Fatty Liver Dise... More >>ase Less << Not Applicable Completed - Taiwan ... More >> China Medical University Hospital Taichung, Taiwan Less <<
NCT01875978 - Completed - -
NCT02541201 Dyslipidemia Phase 2 Completed - -
NCT00928616 Hyperlipidemia Not Applicable Unknown June 2009 Germany ... More >> Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III Homburg, Saarland, Germany, 66421 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.42mL

0.48mL

0.24mL

12.12mL

2.42mL

1.21mL

24.23mL

4.85mL

2.42mL

References

 

Historical Records

Categories